Peficitinib hydrobromide
- CAS No.
- 1353219-05-2
- Chemical Name:
- Peficitinib hydrobromide
- Synonyms
- RMA-849;Peficitinib Hydrobromid;Pemigatinib hydrobromide;Peficitinib hydrobromide;Peficitinib hydrobromide (JAN/USAN);anti-4-((5-Hydroxyadamantan-2-yl)amino)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide hydrobromide;4-(5-Hydroxytricyclo3.3.1.13,7dec-2-yl)amino-1H-pyrrolo2,3-bpyridine-5-carboxamide hydrobromide (1:1) stereoisomer
- CBNumber:
- CB14848254
- Molecular Formula:
- C18H22N4O2.BrH
- Molecular Weight:
- 407.31
- MDL Number:
- MFCD30747936
- MOL File:
- 1353219-05-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| InChI | InChI=1S/C18H22N4O2.BrH/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10;/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22);1H |
|---|---|
| InChIKey | ZUVPMAPXNYGJQC-UHFFFAOYSA-N |
| SMILES | N(C1C(=CN=C2NC=CC=12)C(=O)N)C1C2CC3CC(O)(C2)CC1C3.Br |
| FDA UNII | U55XHZ5X6P |
Peficitinib hydrobromide Chemical Properties, Uses, Production
Uses
Peficitinib (ASP015K) hydrobromide is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1].
Mechanism of action
Peficitinib hydrobromide potently inhibits the JAK-STAT pathway and blocks the signaling of pro-inflammatory cytokines such as IL-6 and IFN-γ. It has the strongest inhibitory activity against JAK3 (IC₅₀ = 0.7 nM), while also taking into account other subtypes (JAK1/2/Tyk2 IC₅₀ 3.9–5.0 nM).
Synthesis
Synthesis of Peficitinib hydrobromide
in vivo
Peficitinib hydrobromide (1-30 mg/kg; p.o.; once daily for 24 days) shows dose-dependent efficacy both in prophylactic and therapeutic dosing regimens in an adjuvant-induced arthritis rat model[1].
| Animal Model: | Seven-weeks-old female Lewis rats, adjuvant-induced arthritis (AIA) model[1] |
| Dosage: | 1, 3, 10, and 30 mg/kg |
| Administration: | Oral administration, once daily for 24 days |
| Result: | Significantly inhibited the increase in paw volume at doses of 1 mg/kg or greater with an ED50 value of 2.7 mg/kg (95% confidence interval: 1.5–4.2 mg/kg). Significantly reduced the bone destruction score at 10 mg/kg or greater and almost fully ameliorated both paw swelling and bone destruction scores at 30 mg/kg. |
IC 50
JAK3: 0.7 nM (IC50); JAK1: 3.9 nM (IC50); Tyk2: 4.8 nM (IC50); JAK2: 5 nM (IC50)
References
[1] Ito M, et al. A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model. J Pharmacol Sci. 2017 Jan;133(1):25-33. DOI:10.1016/j.jphs.2016.12.001
Peficitinib hydrobromide Preparation Products And Raw materials
Raw materials
Preparation Products
Peficitinib hydrobromide Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Hope Chem Co., Ltd., | +21-18501659228 18501659228 | info@hope-chem.com | China | 538 | 55 |
| Cangzhou Enke Pharma-tech Co., Ltd. | 0317-5296180 15533709196 | enkepharma@126.com | China | 2495 | 55 |
| Shanghai Rechem science Co., Ltd. | 021-31433387 15618786686 | sales@rechemscience.com | China | 2969 | 58 |
| Shenzhen Botel Biotechnology Co. Ltd. | 13316949107 13316968096 | 1979313431@qq.com | China | 9619 | 58 |
| Dideu Industries Group Limited | +8617392712697 | 1022@dideu.com | China | 29089 | 58 |
| Chengdu D-innovation Pharmaceutical Co.,LTD | 028-85929779 18881048017 | chenxuanruo@d-innovation.com | China | 208 | 58 |
| Shanghai Yanze Chemical Co., Ltd. | 15345144255 19901447308 | 260924549@qq.com | China | 9989 | 58 |
| Anqing Benro pharmachem Technology Co.,Ltd. | 05565209906 15391842992 | 794263564@qq.com | China | 125 | 58 |
| Chunchuang (Wuhan) Technology Co., Ltd | 15727060112 | yutianchun2007@126.com | China | 9867 | 58 |
| Suzhou Lyco Pharmachem Co.,Ltd. | 13771999217 13771999217 | sales@lycopharmachem.com | China | 218 | 58 |
Related articles
- Seven steps to synthesize Peficitinib hydrobromide
- Peficitinib is a Janus kinase (JAK)1, JAK2, JAK3, and tyrosine kinase (Tyk)2 (pan-JAK) inhibitor recently approved in Japan fo....
- Jan 11,2024
View Latest Price from Peficitinib hydrobromide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-09-18 | Peficitinib Hydrobromid
1353219-05-2
|
1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | ||
![]() |
2026-09-18 | Peficitinib Hydrobromid.
1353219-05-2
|
1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | ||
![]() |
2026-09-18 | Peficitinib Hydrobromide
1353219-05-2
|
1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. |
-

- Peficitinib Hydrobromid
1353219-05-2
- $0.00
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
-

- Peficitinib Hydrobromid.
1353219-05-2
- $0.00
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
-

- Peficitinib Hydrobromide
1353219-05-2
- $0.00
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.




